Innate Pharma Reports First Quarter 2023 Financial Results And Business Update
Exclusive worldwide rights granted to Takeda to research and develop antibody drug conjugates (ADC) using a panel of selected Innate antibodies; Innate to receive $5m upfront payment and eligible to...